Literature DB >> 6406443

Antidepressant response and plasma concentrations of bupropion.

S H Preskorn.   

Abstract

A double-blind multicenter evaluation compared the antidepressant efficacy of bupropion (Wellbutrin) to both placebo and amitriptyline (Elavil, Endep) in adult patients who met DSM-III criteria for major depressive disorder. Steady-state plasma samples were obtained 11-12 hours and 4 hours after the last dose in 50 and 44 patients, respectively, who were treated for 6 weeks with bupropion. There was a curvilinear relationship between antidepressant efficacy and trough plasma bupropion concentrations, with maximum response observed at 5-100 ng/ml and virtually none below 25 ng/ml. The increase in plasma bupropion concentration from the trough level to the 4 hour postdose peak level was also positively related to antidepressant response.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406443

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

1.  A case report of seizure induced by bupropion nasal insufflation.

Authors:  Stanley Hill; Harminder Sikand; Jonathan Lee
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 2.  Pharmacokinetic optimisation of therapy with newer antidepressants.

Authors:  P J Goodnick
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

3.  Comparative efficacy and safety of bupropion and placebo in the treatment of depression.

Authors:  W W Zung; H K Brodie; L Fabre; D McLendon; D Garver
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  Pregnancy Has No Clinically Significant Effect on the Pharmacokinetics of Bupropion or Its Metabolites.

Authors:  Emily E Fay; Lindsay C Czuba; Jennifer E Sager; Sara Shum; Alyssa Stephenson-Famy; Nina Isoherranen
Journal:  Ther Drug Monit       Date:  2021-12-01       Impact factor: 3.681

Review 5.  Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review.

Authors:  Mazda Adli; Christopher Baethge; Andreas Heinz; Nicolas Langlitz; Michael Bauer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-29       Impact factor: 5.760

6.  Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4'-OH-bupropion in vitro.

Authors:  Jennifer E Sager; Lauren S L Price; Nina Isoherranen
Journal:  Drug Metab Dispos       Date:  2016-08-05       Impact factor: 3.922

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.